Applied Genetic Technologies Corporation is a biotechnology company specializing in gene therapy products for inherited orphan ophthalmology diseases in the United States. The company's lead product candidates include treatments for X-linked retinoschisis, Congenital Achromatopsia, and X-linked retinitis pigmentosa, which are eye diseases caused by mutations in single genes. The company is currently in the clinical stage of development.
Applied Genetic's ticker is AGTC
The company's shares trade on the NASDAQ stock exchange
They are based in Alachua, Florida
There are 51-200 employees working at Applied Genetic
It is agtc.com/about
Applied Genetic is in the Healthcare sector
Applied Genetic is in the Biotechnology industry
The following five companies are Applied Genetic's industry peers: